Why the study?
What are the cardiovascular effects of intravenous pentolinium in anesthetized dogs?
What are the cardiovascular effects of intravenous pentolinium in anesthetized dogs?
Pentolinium acts as a potent ganglionic blocker in dogs, blocking the cardiac vagus and sympathetic nervous system while potentially leaving the adrenal medulla incompletely blocked.
Pentolinium confirms potent ganglionic blockade in canine models; leaves open translation to human cardiovascular responses.
Pentolinium (5 mgm./kgm.) injected intravenously into dogs anesthetized with pentobarbital caused the pulse rate to approach that of dogs with surgical cardiac denervation. The higher the initial pulse rate, the greater the decrease after the drug; rates under 100/min. were increased. Changes in arterial pressure followed a similar pattern, and the changes in both systemic and pulmonary arterial pressures were correlated with the changes in pulse rate. The cardiac output was decreased. Pressor responses to injected adrenaline and noradrenaline were greater after pentolinium. Total peripheral resistance, respiratory rate, respiratory minute volume, and oxygen consumption were not changed significantly, but local (hind-leg) resistance was decreased in two of three experiments. Pentolinium abolished or reduced markedly the cardiovascular responses to reduced carotid sinus pressure, tilting, acute hypoxia, large doses of acetylcholine, and hemorrhage. The cardiac vagus and the cardiovascular part of the sympathetic nervous system are blocked, but the experiments suggest that the adrenal medulla may not be completely blocked by 5 mgm./kgm. pentolinium.
No takes yet. Share an insight, caveat, or question.
Spoerel et al. (1956) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: